References
1. United Nations Inter-agency Group for Child Mortality Estimation
(UNIGME). Levels & Trends in Child Mortality: Report 2022, Estimates
developed by the United Nations Inter-agency Group for Child Mortality
Estimation. New York; 2023.
2. Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et
al. Global, regional, and national causes of under-5 mortality in
2000-19: an updated systematic analysis with implications for the
Sustainable Development Goals. The Lancet Child & adolescent health.
2022;6(2):106-15.
3. Katz J, Lee AC, Kozuki N, Lawn JE, Cousens S, Blencowe H, et al.
Mortality risk in preterm and small-for-gestational-age infants in
low-income and middle-income countries: a pooled country analysis.
Lancet. 2013;382(9890):417-25.
4. Wynn A, Bristow CC, Cristillo AD, Murphy SM, van den Broek N, Muzny
C, et al. Sexually Transmitted Infections in Pregnancy and Reproductive
Health: Proceedings of the STAR Sexually Transmitted Infection Clinical
Trial Group Programmatic Meeting. Sex Transm Dis. 2019.
5. Grant JS, Chico RM, Lee AC, Low N, Medina-Marino A, Molina RL, et al.
Sexually Transmitted Infections in Pregnancy: A Narrative Review of the
Global Research Gaps, Challenges, and Opportunities. Sex Transm Dis.
2020;47(12):779-89.
6. Silva M, Florencio G, Gabiatti J, Amaral R, Eleuterio J, Goncalves A.
Perinatal morbidity and mortality associated with chlamydial infection:
a meta-analysis study. The Brazilian journal of infectious diseases.
2011;15(6):533-9.
7. Vallely LM, Egli-Gany D, Wand H, Pomat WS, Homer CSE, Guy R, et al.
Adverse pregnancy and neonatal outcomes associated with Neisseria
gonorrhoeae: systematic review and meta-analysis. Sex Transm Infect.
2021;97(2):104-11.
8. Adachi KN, Nielsen-Saines K, Klausner JD. Chlamydia trachomatis
Screening and Treatment in Pregnancy to Reduce Adverse Pregnancy and
Neonatal Outcomes: A Review. Front Public Health. 2021;9:531073.
9. Medline A, Joseph Davey D, Klausner JD. Lost opportunity to save
newborn lives: variable national antenatal screening policies for
Neisseria gonorrhoeae and Chlamydia trachomatis. International Journal
of STD & AIDS. 2016;28(7):660-6.
10. Romoren M, Sundby J, Velauthapillai M, Rahman M, Klouman E,
Hjortdahl P. Chlamydia and gonorrhoea in pregnant Batswana women: time
to discard the syndromic approach? BMC infectious diseases.
2007;7(27):Published online.
11. Wynn A, Mussa A, Ryan R, Hansman E, Simon S, Bame B, et al.
Evaluating the diagnosis and treatment of Chlamydia trachomatis and
Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal
consequences in Gaborone, Botswana: protocol for the Maduo study. BMC
infectious diseases. 2022;22(1):229.
12. Centers for Disease Control and Prevention. Sexually Transmitted
Infections Treatment Guidelines, 2021. 2021.
13. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et
al. The REDCap consortium: Building an international community of
software platform partners. J Biomed Inform. 2019;95:103208.
14. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and
causes of preterm birth. Lancet. 2008;371(9606):75-84.
15. Institute of Medicine Committee on Improving Birth Outcomes. The
Problem of Low Birth Weight. In: Bale J, Stoll B, Lucas A, editors.
Improving Birth Outcomes: Meeting the Challenge in the Developing World
Washington (DC: National Academies Press; 2003.
16. World Health Organization. WHO recommendations on antenatal care for
a positive pregnancy experience. Guideline. 2016.
17. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT
alcohol consumption questions (AUDIT-C): an effective brief screening
test for problem drinking. Ambulatory Care Quality Improvement Project
(ACQUIP). Alcohol Use Disorders Identification Test. Archives of
internal medicine. 1998;158(16):1789-95.
18. Wooldridge J. Introductory Econometrics: A Modern Approach. 4th ed:
South-Western; 2009.
19. Muller CJ, MacLehose RF. Estimating predicted probabilities from
logistic regression: different methods correspond to different target
populations. International journal of epidemiology. 2014;43(3):962-70.
20. Tang W, Mao J, Li KT, Walker JS, Chou R, Fu R, et al. Pregnancy and
fertility-related adverse outcomes associated with Chlamydia trachomatis
infection: a global systematic review and meta-analysis. Sex Transm
Infect. 2020;96(5):322-9.
21. World Health Organization. Global health sector strategies on,
respectively, HIV, viral hepatitis and sexually
transmitted infections for the period 2022-2030. Geneva.; 2022. Contract
No.: CC BY-NC-SA 3.0 IGO.
22. Bretelle F, Loubière S, Desbriere R, Loundou A, Blanc J, Heckenroth
H, et al. Effectiveness and Costs of Molecular Screening and Treatment
for Bacterial Vaginosis to Prevent Preterm Birth: The AuTop Randomized
Clinical Trial. JAMA pediatrics. 2023.
23. Batteiger BE, Xu F, Johnson RE, Rekart ML. Protective immunity to
Chlamydia trachomatis genital infection: evidence from human studies. J
Infect Dis. 2010;201 Suppl 2(S2):S178-89.
24. Ryan G AT, McNeeley S, Baselski V, Drummond D. Chlamydia trachomatis
infection in pregnancy and effect of treatment on outcome. American
Journal of Obstetrics & Gynecology. 1990;162(1):34-9.
25. Martin DH, Eschenbach DA, Cotch MF, Nugent RP, Rao AV, Klebanoff MA,
et al. Double-Blind Placebo-Controlled Treatment Trial of Chlamydia
trachomatis Endocervical Infections in Pregnant Women. Infect Dis Obstet
Gynecol. 1997;5(1):10-7.
26. Cohen I VJ, Calkins BM. Improved pregnancy outcome following
successful treatment of chlamydial infection. JAMA. 1990;263(23):3160-3.
27. Rastogi S DB, Salhan S, Mittal A. Effect of treatment for Chlamydia
trachomatis during pregnancy. Int J Gynaecol Obstet. 2003;80(2):129-37.
28. McGregor JA, French JI, Richter R, Vuchetich M, Bachus V, Seo K, et
al. Cervicovaginal microflora and pregnancy outcome: results of a
double-blind, placebo-controlled trial of erythromycin treatment. Am J
Obstet Gynecol. 1990;163(5 Pt 1):1580-91.
29. Peters R, Klausner J, Feucht U, Vos L, Medina-Marino A. Aetiologic
testing compared with syndromic management for sexually transmitted
infections in HIV-infected pregnant women in South Africa: a
non-randomised prospective cohort study. BJOG An International Journal
of Obstetrics & Gynaecology. 2020.
30. Medina-Marino A, Mudau M, Kojima N, Peters RP, Feucht UD, Vos L, et
al. Persistent Chlamydia trachomatis, Neisseria gonorrhoeae or
Trichomonas vaginalis positivity after treatment among human
immunodeficiency virus-infected pregnant women, South Africa. Int J STD
AIDS. 2020;31(4):294-302.
31. Mussa A, Wynn A, Ryan R, Babalola C, Simon S, Ramontshonyana K, et
al. High Cure Rate Among Pregnant Women in a Chlamydia trachomatis and
Neisseria gonorrhoeae Testing and Treatment Intervention Study in
Gaborone, Botswana. Sex Transm Dis. 2023;50(2):124-7.
32. Low N. Chlamydia trachomatis and reproductive health: what can we
learn from systematic reviews of observational studies? Sex Transm
Infect. 2020;96(5):315-7.
33. Vallely AJ, Pomat WS, Homer C, Guy R, Luchters S, Mola GDL, et al.
Point-of-care testing and treatment of sexually transmitted infections
to improve birth outcomes in high-burden, low-income settings: Study
protocol for a cluster randomized crossover trial (the WANTAIM Trial,
Papua New Guinea). Wellcome open research. 2019;4:53.
34. Torgerson DJ. Contamination in trials: is cluster randomisation the
answer? Bmj. 2001;322(7282):355-7.